ÂÜÀòÂÒÂ×

Jim Broderick is an accomplished biotech executive with more than 20 years of experience in the industry. He was Co-Founder and Chairman of Ra Pharmaceuticals (NASDAQ RARX, acquired by UCB), founding CEO of SetPoint Medical, and Co-Founder and Chairman of Promedior (acquired by Roche), while he was a partner at the venture capital firm Morgenthaler Ventures. Jim founded Palleon in collaboration with the venture capital firm SR One, where he served as an Entrepreneur-in-Residence. He earned a B.S. in mechanical engineering from MIT and an M.D. from UMass Medical School.